Metrikler
Yayın
24
Açık Erişim
1
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2018 - Devam Ediyor
2018 - Devam EdiyorDoktora
Ankara Üniversitesi, Biyoteknoloji Enstitüsü, Biyoteknoloji Anabilim Dalı, Türkiye
2014 - 2017
2014 - 2017Yüksek Lisans
Ankara Üniversitesi, Biyoteknoloji Enstitüsü, Biyoteknoloji Anabilim Dalı, Türkiye
2001 - 2005
2001 - 2005Lisans
Gazi Üniversitesi, Fen Fakültesi, Biyoloji, Türkiye
Araştırma Alanları
Biyoteknoloji
Viroloji
Moleküler Biyoloji ve Genetik
Akademik Ünvanlar / Görevler
2022 - Devam Ediyor
2022 - Devam EdiyorÖğretim Görevlisi
Ankara Üniversitesi, Hepatoloji Enstitüsü
Makaleler
Tümü (12)
SCI-E, SSCI, AHCI (10)
SCI-E, SSCI, AHCI, ESCI (12)
ESCI (2)
Scopus (11)
TRDizin (5)
2024
20241. A brief communication of patients with homozygous C282Y mutation-related hereditary hemochromatosis
GÖKCAN H., Oz D., BODAKÇİ E., TUNÇ E., İDİLMAN R.
HEPATOLOGY FORUM
, cilt.5, sa.3, ss.161-164, 2024 (ESCI, Scopus, TRDizin)
2024
20242. Chronic hepatitis delta with normal ALT and hepatitis D viremia: unravelling its natural history
Gulnar M. O., Kamal H., Palom A., Arici S., Esteban R., TUNÇ E., et al.
JOURNAL OF HEPATOLOGY
, 2024 (SCI-Expanded, Scopus)
2023
20233. The role of PAGE-B score in predicting the development of hepatocelular cancer in patients with chronic delta hepatitis
KESKİN O., Kalkan C., ÖZTÜRK B., Caliskan A., Sahin H., Gumussoy M., et al.
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded, Scopus)
2023
20234. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta
Kalkan Ç., Yılmaz Y., Erdoğan B. D., SAVAŞ B., Yurdcu E., Çalışkan A., et al.
Journal of Viral Hepatitis
, cilt.30, sa.5, ss.406-416, 2023 (SCI-Expanded, Scopus)
2022
20225. FUNCTIONAL CURE WITH LONAFARNIB-BASED THERAPY IN CHRONIC HEPATITIS DELTA
Yurdaydin C., Yurdcu E., Gumussoy M., KESKİN O., Gencdal G., Akyildiz M., et al.
HEPATOLOGY
, cilt.76, 2022 (SCI-Expanded, Scopus)
2022
20226. A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis
Yurdaydin C., Keskin O., Yurdcu E., Caliskan A., Onem S., Karakaya F., et al.
HEPATOLOGY
, cilt.75, sa.6, ss.1551-1565, 2022 (SCI-Expanded, Scopus)
2020
20207. Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan
Husseini A. A., Saeed K. M. I., Yurdcu E., BOZDAYI A. M.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.31, sa.9, ss.658-666, 2020 (SCI-Expanded, Scopus, TRDizin)
2019
20198. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits
Yasar O., Karatayli E., Cengiz G., Kizilpinar M., Yurdcu E., ALBAYRAK DELİALİOĞLU R., et al.
JOURNAL OF MEDICAL VIROLOGY
, cilt.91, sa.12, ss.2174-2181, 2019 (SCI-Expanded, Scopus)
2019
20199. Epidemiology of blood-borne viral infections in Afghanistan
Husseini A. A., Saeed K. M. I., Yurdcu E., SERTÖZ Ş. R., BOZDAYI A. M.
ARCHIVES OF VIROLOGY
, cilt.164, sa.8, ss.2083-2090, 2019 (SCI-Expanded, Scopus)
2019
201910. Evaluation of the results of MOTAKK hepatitis C virus RNA genotyping and hepatitis delta virus external quality assessment programs during 2015-2016
Karatayli E., Soydemir E., Aksoy Z. B., Kizilpinar M., Kocak A. A., Karatayli S. C., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.30, sa.11, ss.957-963, 2019 (SCI-Expanded, Scopus, TRDizin)
2018
201811. Failure of Direct-Acting Antiviral Agents Due to Incomplete Hepatitis C Virus Genotyping
Akinci E., Yurdcu E., Orkun Ozbay B., Bodur H.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
, cilt.24, sa.3, ss.96-98, 2018 (ESCI, TRDizin)
2018
201812. Evaluation of 2015-2016 MOTAKK HBV DNA and HCV RNA External Quality Assessment National Program Results
Karatayli E., Soydemir E., Aksoy Z. B., Kizilpinar M., Altay Kocak A., Karatayli S. C., et al.
MIKROBIYOLOJI BULTENI
, cilt.52, sa.4, ss.348-366, 2018 (SCI-Expanded, Scopus, TRDizin)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2019
20191. NATURAL HISTORY OF INACTIVE HBsAg CARRIERS: A 10-YEAR PROSPECTIVE FOLLOW-UP STUDY
Yurdaydin C., Keskin O., Yurdcu E., Yakut M., Seven G., Kabacam G., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70, (Özet Bildiri)
2019
20192. TREATMENT DISCONTINUATION IN HBEAG-NEGATIVE CHRONIC HEPATIT B IS A VIABLE OPTION IN NON-CIRRHOTIC GENOTYPE D CHRONIC HEPATITIS B PATIENTS
ŞAH ÜNAL F. T., Keskin O., Yurdcu E., Yilmaz Y., KARAKAYA M. F., Kartal A., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70, (Özet Bildiri)
2019
20193. 10 YILLIK PROSPEKTİF ÇALIŞMADA DÜŞÜK VİRAL YÜKLÜ HBV TAŞIYICILARI REAKTİVASYONDAN ZİYADE HBSAG KAYBETMEYE YATKINDIR.
KESKİN O., YAKUT M., YURDCU E., KALKAN Ç., AGAYEVA S., YILMAZ Y., et al.
12. ULUSAL HEPATOLOJİİ KONGRESİ, Antalya, Türkiye, 1 - 05 Mayıs 2019, (Özet Bildiri)
2019
20194. Frequency, severity and impact of Peg-IFNa-associated flares in HDV infection: Results from the HIDIT-II study
Hardtke S., Wedemeyer H., Caruntu F. A., Curescu M., Kendal Y., AKARCA U. S., et al.
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70, (Özet Bildiri)
2019
20195. HEV seroprevalence in blood donors in Turkey: Comparison of two commercial anti-HEV total Ab ELISA kit
Yasar O., Cengiz G., Karatayli E., Kizilpinar M., Yurdcu E., ALBAYRAK DELİALİOĞLU R., et al.
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70, (Özet Bildiri)
2018
20186. Comparison of the efficacy of short term and long term nucleos(t)ide analog treatment in chronic delta hepatitis
YURTAYDIN S. C., KESKİN O., KARAKAYA M. F., YILMAZ Y., ÇALIŞKAN KARTAL A., MELEKOĞLU ELLİK Z., et al.
35. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Türkiye, 21 Kasım 2018, (Özet Bildiri)
2018
20187. Nonnvasve Fbross Scores Are Not Useful for Predcton of Response to Treatment n Chronc Delta Hepatts
KESKİN O., YURDCU E., KALKAN Ç., ÇALIŞKAN KARTAL A., ELLİK Z., BOZDAYI A. M., et al.
AASLD LIVER MEETING 2018, San-Francisco, Kostarika, 9 - 13 Kasım 2018, (Özet Bildiri)
2018
20188. Noninvasive Fibrosis Scores Are Not Useful for Prediction of Response to Treatment in Chronic Delta Hepatitis
Keskin O., Yurdcu E., Kalkan C., Kartal A., Ellik Z., Bozdayi M., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)
2018
20189. A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis-analysis from the LOWR HDV-2 study using the robogene (R) real-time qPCR HDV RNA assay
Yurdaydin C., Idilman R., Keskin O., Kalkan C., Karakaya F. M., Caliskan A., et al.
16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), Toronto, Kanada, 14 - 17 Haziran 2018, cilt.25, ss.10, (Özet Bildiri)
2017
201710. Value of non-invasive fibrosis markers in chronic hepatitis D
Kalkan C., Karakaya F., Keskin O., Kartal A., Karatayli E., Bozdayi M., et al.
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Hollanda, 19 - 23 Nisan 2017, cilt.66, (Özet Bildiri)
2017
201711. A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis-end of treatment results from the LOWR HDV-2 study
Yurdaydin C., Idilman R., Keskin O., Kalkan C., Karakaya M. F., Caliskan A., et al.
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Hollanda, 19 - 23 Nisan 2017, cilt.66, (Özet Bildiri)
2017
201712. The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis
Yurdaydin C., Idilman R., Kalkan C., Karakaya M. F., Caliskan A., Keskin O., et al.
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Hollanda, 19 - 23 Nisan 2017, cilt.66, (Özet Bildiri)